广东白癜风医院有那几个(内蒙腹部白癜风治疗) (今日更新中)

The Trump campaign has dropped a lawsuit in Arizona in which they were requesting a review of ballots cast on Election Day.The lawsuit was filed Saturday and claimed some voters were worried their ballots didn’t count correctly if the machines classified a race as “overvoted”, where more than one selection was made by mistake.A judge in Phoenix held a six-hour evidentiary hearing Thursday in the case. Later that night, CNN reports, the lawyer for the Trump campaign revised their earlier request and said they would only seek a review of vote counts if the number of “overvotes” exceeded the margin of victory.In paperwork filed with the court Friday morning, the secretary of state and officials with Maricopa County noted that the difference in votes between President-elect Joe Biden and President Donald Trump is 11,414 votes, with 10,315 ballots left to be counted.They also said 191 votes classified as “overvotes” in the presidential race, and they said that number is consistent with previous elections.Friday, lawyers for President Trump’s reelection campaign dropped the lawsuit, filing a notice of “partial mootness” with the court."Since the close of yesterday's hearing, the tabulation of votes statewide has rendered unnecessary a judicial ruling as to the presidential electors," wrote Kory Langhofer, a lawyer for the Trump campaign, in court papers. The lawyer said he did want the judge to rule on their requests to review votes for two down-ballot races. 1485

The US House of Representatives will vote on whether to legalize marijuana across the country in September. This would be the first time a chamber of Congress has ever voted on removing marijuana from the Controlled Substances Act.Cannabis was included as what is called a Schedule I drug under the Controlled Substances Act in 1970. Schedule I drugs are defined as having a high potential for abuse and no medical benefit. Other Schedule I drugs include heroin, LSD, ecstasy and peyote.On Friday, representatives were informed the MORE Act will come up for a vote in the September work period of the House.The MORE Act - Marijuana Opportunity Reinvestment and Expungement Act - will expunge some cannabis records and create grant opportunities for people who have been negatively impacted by the criminalization of marijuana in addition to removing it from its Schedule I classification, according to Politico.Marijuana is already legal in 11 states, despite the federal designation as a Schedule I drug.Senate Majority Leader Mitch McConnell is opposed to the act, and some say the odds of it passing the senate are very slim.Even if the MORE Act passes both chambers of Congress, it would not make sales of marijuana legal. Regulation of marijuana would be left to states to decide how to handle it. 1310

The Senate Intelligence Committee's leaders said Wednesday they believed that the intelligence community's 2017 assessment of election meddling was correct, breaking with Republicans on the House Intelligence Committee who questioned the conclusion that the Russians were trying to help President Donald Trump get elected."There is no doubt that Russia undertook an unprecedented effort to interfere with our 2016 election," Senate Intelligence Chairman Richard Burr, a North Carolina Republican, said in a statement. "Committee staff have spent 14 months reviewing the sources, tradecraft, and analytic work, and we see no reason to dispute the conclusions."The top Democrat on the committee, Sen. Mark Warner of Virginia, said that "after a thorough review, our staff concluded that the ICA conclusions were accurate and on point. The Russian effort was extensive, sophisticated and ordered by President Putin himself for the purpose of helping Donald Trump and hurting Hilary Clinton." 996

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690

The revolution is coming. The much-anticipated video premiere of “Hamilton” will be available on Disney+ Friday, July 3.Here are the details: The video is 2 hours and 41 minutes long, and includes a minute countdown for intermission. It was recorded using several cameras during two of the last performances of the initial 2016 Broadway run of the hit musical, and includes most of the original cast.It will only be available on the Disney+ streaming service starting at 12 a.m. PT/3 a.m. ET on Friday. Disney is holding a Twitter watch party later in the day at 7 p.m. ET/4 p.m. PT. 591

来源：资阳报